|
GNAI1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.3726355042063E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.61719543207073E-11 |
| Normal-vs-Stage2 |
1.684790E-03 |
| Normal-vs-Stage3 |
1.67119995619913E-09 |
| Normal-vs-Stage4 |
3.25509952325831E-10 |
| Stage1-vs-Stage2 |
6.844100E-02 |
| Stage1-vs-Stage3 |
4.902600E-01 |
| Stage1-vs-Stage4 |
1.880060E-02 |
| Stage2-vs-Stage3 |
4.214300E-02 |
| Stage2-vs-Stage4 |
3.903800E-03 |
| Stage3-vs-Stage4 |
1.599010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.0715999722637E-09 |
| Normal-vs-AfricanAmerican |
2.067900E-02 |
| Normal-vs-Asian |
8.01939625816317E-11 |
| Caucasian-vs-AfricanAmerican |
1.750190E-01 |
| Caucasian-vs-Asian |
1.880390E-02 |
| AfricanAmerican-vs-Asian |
4.274300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.27659999530294E-08 |
| Normal-vs-Female |
3.44380080008477E-11 |
| Male-vs-Female |
9.815200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.1793999938069E-09 |
| Normal-vs-Age(41-60Yrs) |
6.30719998451212E-09 |
| Normal-vs-Age(61-80Yrs) |
1.59120999999596E-05 |
| Normal-vs-Age(81-100Yrs) |
8.134400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.332380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.129900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.193800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.302200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.593000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.573200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.73589999999636E-05 |
| Classical-VS-Follicular |
1.75579999994735E-06 |
| Classical-VS-Other |
9.585600E-01 |
| Classical-VS-Normal |
2.93070001600171E-09 |
| Tall-VS-Follicular |
8.45720160569385E-11 |
| Tall-VS-Other |
3.250800E-01 |
| Tall-VS-Normal |
1.70430336510208E-12 |
| Follicular-VS-Other |
1.242850E-01 |
| Follicular-VS-Normal |
3.023700E-02 |
| Other-VS-Normal |
9.903200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31889999999135E-06 |
| Normal-vs-N1 |
3.14750003838071E-10 |
| N0-vs-N1 |
1.037210E-03 |
|
|
